News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
TANG CAPITAL PARTNERS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 8.6% stake in Bionomics Limited |
| 06/06/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.1% stake in AVROBIO, Inc. |
| 04/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/31/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 10% stake in Quince Therapeutics, Inc. |
| 03/17/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 10% stake in Bellerophon Therapeutics, Inc. |
| 03/13/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.3% stake in Adicet Bio, Inc. |
| 03/06/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 9.7% stake in Jounce Therapeutics, Inc. |
| 02/24/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.8% stake in Elevation Oncology, Inc. |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/27/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.9% stake in Aligos Therapeutics, Inc. |
| 12/27/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 7.4% stake in Tonix Pharmaceuticals Holding Corp. |
| 12/19/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/26/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.6% stake in Albireo Pharma, Inc. |
| 07/25/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/06/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.2% stake in Veru, Inc. |
| 06/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/26/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.7% stake in KalVista Pharmaceuticals, Inc. |
| 05/13/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/28/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.4% stake in BioAtla, Inc. |
| 03/24/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.1% stake in Altimmune, Inc. |
| 03/04/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 7.3% stake in TCR2 Therapeutics Inc. |
| 09/22/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/17/2021 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.3% stake in aTyr Pharma, Inc. |
| 06/03/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/19/2020 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 10% stake in to amend the Schedule 13D filed by Tang Capital Partners, LP and related parties on October 14, 2008 Heron Therapeutics, Inc. |
| 03/16/2020 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.7% stake in LifeSci Acquisition Corp. |
| 11/22/2019 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.8% stake in AnaptysBio, Inc. |
| 11/18/2019 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 5.8% stake in Evolus, Inc. |
| 10/31/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/28/2019 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.8% stake in Cellectar Biosciences, Inc. |
| 01/16/2018 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 8.1% stake in Rocket Pharmaceuticals, Inc. |
| 08/19/2016 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 9.6% stake in Cyclacel Pharmaceuticals, Inc. |
|
|
|